Peregrine Capital Management LLC Purchases 37,840 Shares of Guardian Pharmacy Services, Inc. $GRDN

Peregrine Capital Management LLC raised its stake in Guardian Pharmacy Services, Inc. (NYSE:GRDN) by 21.4% during the 2nd quarter, Holdings Channel reports. The fund owned 214,379 shares of the company’s stock after acquiring an additional 37,840 shares during the period. Peregrine Capital Management LLC’s holdings in Guardian Pharmacy Services were worth $4,568,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently bought and sold shares of the company. KLP Kapitalforvaltning AS bought a new position in Guardian Pharmacy Services in the 2nd quarter valued at about $75,000. Meeder Asset Management Inc. bought a new position in Guardian Pharmacy Services in the 1st quarter valued at about $88,000. Dynamic Technology Lab Private Ltd bought a new position in Guardian Pharmacy Services in the 1st quarter valued at about $233,000. Envestnet Asset Management Inc. raised its holdings in Guardian Pharmacy Services by 7.1% in the 2nd quarter. Envestnet Asset Management Inc. now owns 12,126 shares of the company’s stock valued at $258,000 after acquiring an additional 805 shares during the period. Finally, Bank of New York Mellon Corp raised its holdings in Guardian Pharmacy Services by 55.9% in the 1st quarter. Bank of New York Mellon Corp now owns 21,196 shares of the company’s stock valued at $451,000 after acquiring an additional 7,597 shares during the period.

Analysts Set New Price Targets

Several research analysts have weighed in on GRDN shares. Truist Financial increased their price target on shares of Guardian Pharmacy Services from $28.00 to $30.00 and gave the company a “buy” rating in a report on Friday, September 26th. Oppenheimer assumed coverage on shares of Guardian Pharmacy Services in a report on Friday, October 10th. They issued an “outperform” rating and a $30.00 price target on the stock. Wall Street Zen lowered shares of Guardian Pharmacy Services from a “strong-buy” rating to a “buy” rating in a research report on Friday, October 3rd. Finally, Weiss Ratings restated a “sell (d+)” rating on shares of Guardian Pharmacy Services in a research report on Wednesday, October 8th. Three investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $29.33.

Guardian Pharmacy Services Stock Up 1.5%

Shares of NYSE:GRDN opened at $29.49 on Wednesday. The company’s 50 day moving average price is $26.37 and its two-hundred day moving average price is $23.60. Guardian Pharmacy Services, Inc. has a 12-month low of $17.29 and a 12-month high of $30.39. The firm has a market cap of $1.87 billion and a PE ratio of -19.40.

Guardian Pharmacy Services Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.